1. Kasagi K, Miyamoto S, Endo K, Sasayama S, Takeuchi R, Hidaka A, et al. Increased uptake of iodine-131 in metastases of differentiated thyroid carcinoma associated with less severe hypothyroidism following total thyroidectomy.Cancer 72: 1983–1990, 1993.
2. Eishima K, Izumi M, Tominaga T, Kimura H, Yokoyama N, Morita S, et al. The significance of131I treatment of metastatic thyroid carcinoma,Int J Oncol 2: 877–882, 1993.
3. Schlumberger M, Challeton C, Vathaire FD, Travagli J-P, Gardet P, Lumbroso J-D, et al. Radioactivie iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma.J Nucl Med 37: 598–605, 1996.
4. Fukuma N, Petersen VB, McLachlan SM, Pegg CAS, Rees Smith B. Human monoclonal thyroglobulin autoantibodies of high affinity. I. Production, characterisation and interaction with murine monoclonal thyroglobulin antibodies.Autoimmunity 10: 291–295, 1991.
5. Misaki T, Miyamoto S, Alam MS, Kasagi K, Konishi J. Tumoricidal cytokines enhance radioiodine uptake in cultured thyroid cancer cells.J Nucl Med 37: 646–648, 1996.